A5101739906- Dementia and Cognitive Impairment Research
- Blood Pressure and Hypertension Studies
- Schizophrenia research and treatment
- Aging, Elder Care, and Social Issues
- Psychosomatic Disorders and Their Treatments
- Stroke Rehabilitation and Recovery
- Homelessness and Social Issues
- Healthcare Decision-Making and Restraints
- Intracerebral and Subarachnoid Hemorrhage Research
- Smoking Behavior and Cessation
- Context-Aware Activity Recognition Systems
- Neurological and metabolic disorders
- Pharmaceutical Practices and Patient Outcomes
- Palliative Care and End-of-Life Issues
- Substance Abuse Treatment and Outcomes
- Health, Environment, Cognitive Aging
- Migration, Aging, and Tourism Studies
- Delphi Technique in Research
- Geriatric Care and Nursing Homes
- Health Systems, Economic Evaluations, Quality of Life
- Psychiatric care and mental health services
- Epilepsy research and treatment
Ontario Shores Centre for Mental Health Sciences
2022-2024
University of Toronto
2020-2024
Centre for Addiction and Mental Health
2020-2021
Dementia is a neurodegenerative condition that combines several diseases and impacts millions around the world those them. Although cognitive impairment profoundly disabling, it noncognitive features of dementia, referred to as Neuropsychiatric Symptoms (NPS), are most closely associated with diminished quality life. Agitation aggression (AA) in people living dementia (PwD) contribute distress increased healthcare demands. Current assessment methods rely on caregiver intervention reporting...
Dementia is a neurodegenerative disorder that has been growing among elder people over the past decades. This growth profoundly impacts quality of life for patients and caregivers due to symptoms arising from it. Agitation aggression (AA) are some with severe dementia (PwD) in long-term care or hospitals. AA not only causes discomfort but also puts others at potential risk. Existing monitoring solutions utilizing different wearable sensors integrated Artificial Intelligence (AI) offer way...
Abstract Background Neuropsychiatric symptoms (NPS) of dementia are a heterogenous group non‐cognitive and behaviors that occur in up to 90% individuals with the condition. Characterizing NPS is major issue current methods unreliable as they rely on subjective observations. Automatic identification using central peripheral physiological markers may be helpful detect behaviors, allow for early intervention, prevent critical incidents patients dementia. Methods This study will use modified...
Multiple cerebral microhemorrhages are a common feature of amyloid angiopathy (CAA), cerebrovascular disorder contributing to cognitive impairment.While CAA-related and functional deterioration has been wellestablished within the literature, emerging work suggests that neuropsychiatric symptoms (NPS), such as depression, behavioural issues, personality changes, clinical manifestations disorder.Recent seminal revealed patients with probable CAA were shown experience various NPS, especially...
Abstract Background Behavioral and psychological symptoms of dementia (BPSD) are highly prevalent in patients with during the course disease. Among BPSD symptoms, agitation aggression a source distress for both their caregivers. In this study, we investigated impact on Quality Life (QoL) living long‐term care homes or admitted to psychiatric inpatient units. Method Data were obtained from Standardizing Care Neuropsychiatric Symptoms Dementia (StaN) multisite trial conducted Canada. Agitation...
Abstract Background Behavioral and psychological symptoms in dementia (BPSD) are highly prevalent patients with Alzheimer’s (AD). We examined sex differences the frequency severity of BPSD advanced AD residing long term care or admitted to inpatient psychiatric units. Also, symptom clusters were explored. Method analyzed data from Standardizing Care for Neuropsychiatric Symptoms Quality Life Dementia (StaN) study (ClinicalTrials.gov/NCT03672201). was assessed Inventory Clinician rating...
Dementia is a chronic and irreversible condition characterized by progressive cognitive functional decline, along with non-cognitive Neuropsychiatric Symptoms (NPS) that significantly affect patients' quality of life. This study explores the application artificial intelligence using wearable sensor data collected from dementia patients (PwD) to develop an AI system for detecting NPS, particularly episodes agitation, in institutional setting. We present preliminary results real-world at...
Background: Agitation and aggression (AA) occur frequently in patients with dementia (PwD), cause distress to PwD caregivers. This study will investigate whether physiological parameters, such as actigraphy, heart rate variability, temperature, electrodermal activity, measured via wearable sensors, correlate AA PwD. It also explore these parameters could be compiled create a pre-agitation biometric marker capable of predicting episodes Methods: take place at Ontario Shores Centre for Mental...
Objectives: Agitation and aggression (AA) occur frequently in patients with dementia (PwD), are challenging to manage, distressing for PwD, families, caregivers, healthcare systems. Physiological parameters, such as Actigraphy, Heart Rate Variability, Electrodermal Activity, measured via wearable sensors correlated AA PwD. It is unclear whether these parameters could be compiled into an operational algorithm create a pre-agitation biometric marker (i.e. of Autonomous Nervous System’s...
Symposium Overview Neuropsychiatric symptoms of dementia (NPSD) are diverse and prevalent group that impose significant challenge for people living with (PLWD), their caregivers, the system care. Quality standards in all jurisdictions stipulate individualized, non-pharmacological intervention NPSD needs to be provided PLWD before pharmacological interventions used due modest effect size risks involved using latter. Implementation individualized plan care face many challenges including...
Abstract Background To systematically review literature on informant based tools for the diagnosis and monitoring of neurocognitive disorders make evidence recommendations to clinicians researchers as part 5th Canadian Consensus Conferences Diagnosis Treatment Dementia. Method A systematic search was performed in MEDLINE, PsycINFO, Cochrane, EMBASE databases. Limits used searches were humans, English, age above 45. Articles that validated or described their key properties included. The...
Abstract Background Polypharmacy is common in patients with dementia and associated several adverse effects. Factors polypharmacy behavioral psychological symptoms of (BPSD) are unclear. This study examined the factors general psychotropic BPSD. Method Baseline data was obtained from Standardizing Care for Neuropsychiatric Symptoms Quality Life Dementia (StaN) study, a multisite trial currently underway Canada at long‐term care inpatient sites. The Cohen‐Mansfield Agitation Inventory (CMAI)...